北陆药业：关于控股子公司海昌药业通过巴西国家卫生监督局GMP认证的公告

Core Viewpoint - Beilu Pharmaceutical announced that its subsidiary, Zhejiang Haichang Pharmaceutical Co., Ltd., has received official GMP certification from the Brazilian National Health Surveillance Agency [1]. Group 1 - The certification indicates that Haichang Pharmaceutical meets the required standards for drug production quality management [1]. - This development may enhance the company's credibility and market access in Brazil, potentially leading to increased sales and growth opportunities [1].